Product image of Mestinon 10 (Pyridostigmine Bromide) supplied by GNH India

Mestinon 10

Active Ingredient:
Pyridostigmine Bromide
Origin:
EU

Mestinon 10 (Pyridostigmine Bromide)

Pyridostigmine bromide, the active ingredient in Mestinon 10, is a cholinesterase inhibitor presented as an oral tablet for oral administration. It works by increasing acetylcholine at neuromuscular junctions and is used to improve muscle strength in patients with myasthenia gravis and to alleviate symptoms of orthostatic hypotension.

GNH India supplies Mestinon 10 as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to strict quality standards and provides reliable global distribution.

Manufacturer / TM Owner

Viatris Healthcare Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Mestinon (pyridostigmine bromide) is used in disorders that involve impaired neuromuscular transmission.

  • Myasthenia gravis: improves skeletal muscle strength and reduces fatigue.
  • Orthostatic hypotension: lessens the drop in blood pressure upon standing.
  • Myasthenic crisis: supports respiratory muscle function during acute exacerbations.

How It Works

  • Pyridostigmine bromide reversibly inhibits acetylcholinesterase, the enzyme that degrades acetylcholine at cholinergic synapses. By blocking this enzyme, the drug raises the concentration of acetylcholine in the neuromuscular junction, enhancing cholinergic transmission and improving muscle contraction in affected patients.

Side Effects

Common side effects are usually mild and related to increased cholinergic activity.

Common Side Effects

  • Nausea: mild to moderate upset stomach.
  • Diarrhea: loose stools occurring after dosing.
  • Abdominal cramps: intermittent stomach discomfort.
  • Increased salivation: excess drooling or oral secretions.
  • Muscle cramps: involuntary tightening of skeletal muscles.
  • Sweating: excessive perspiration.

Serious or Rare Side Effects

  • Cholinergic crisis: severe muscle weakness and respiratory failure.
  • Bradycardia: markedly slow heart rate requiring monitoring.
  • Bronchospasm: narrowing of airways causing breathing difficulty.
  • Seizures: rare convulsive episodes.
  • Anaphylaxis: life‑threatening allergic reaction.
  • Severe rash or skin eruption: indicative of hypersensitivity.

Precautions & Warnings

Before initiating therapy, consider the following safety measures.

  • Dose titration: adjust gradually based on clinical response and tolerance.
  • Renal impairment: monitor renal function and modify dose if needed.
  • Cardiac disease: use cautiously in patients with bradyarrhythmias.
  • Pregnancy: risk category unknown; discuss potential benefits and risks with a healthcare professional.
  • Concomitant anticholinergic drugs: may reduce therapeutic effect.
  • Store at ambient temperature: keep below 25 °C, retain in original packaging, and protect from moisture.

Avoid Interactions

Pyridostigmine bromide can interact with several medicines, altering its efficacy or safety.

Major Interactions (Avoid)

  • Beta‑blockers: may exacerbate bradycardia.
  • Muscarinic antagonists (e.g., atropine): antagonize pyridostigmine’s action.
  • Other cholinesterase inhibitors: additive cholinergic effects can lead to toxicity.

Moderate Interactions (Monitor Closely)

  • Antihypertensives: may enhance hypotensive response.
  • Anesthetic agents (e.g., succinylcholine): prolonged neuromuscular blockade.
  • Diuretics: potential electrolyte disturbances requiring monitoring.

Frequently Asked Questions

Mestinon 10, containing pyridostigmine bromide, is prescribed for myasthenia gravis to improve muscle strength, for orthostatic hypotension to reduce blood‑pressure drops on standing, and for acute myasthenic crises to support respiratory muscles.

Pyridostigmine bromide reversibly blocks the enzyme acetylcholinesterase, preventing the breakdown of acetylcholine at neuromuscular junctions. This increases the amount of acetylcholine available to stimulate muscle receptors, enhancing neuromuscular transmission and muscle contraction.

The appropriate dose of Mestinon 10 is determined individually by a qualified prescriber based on the patient’s condition, response, and tolerability. Dosage adjustments are made according to clinical guidelines and patient monitoring.

The safety of pyridostigmine bromide in pregnancy and lactation has not been definitively established. Healthcare providers should weigh potential benefits against possible risks and discuss any concerns with the patient before prescribing.

To request Mestinon 10, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Mestinon 10 (pyridostigmine) is a reversible, short‑acting cholinesterase inhibitor commonly used for myasthenia gravis and orthostatic hypotension. Compared with longer‑acting agents such as neostigmine, pyridostigmine has a more favorable side‑effect profile and is preferred for chronic outpatient management.

Mestinon 10 should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in their original container, protect them from moisture and direct sunlight, and ensure they are out of reach of children.

Mestinon 10 is taken orally, usually with a glass of water. It can be taken with or without food, but consistency with meals may help reduce gastrointestinal discomfort. The exact timing and frequency are set by the prescribing clinician.

The most serious risks include cholinergic crisis, which can cause severe muscle weakness and respiratory failure, as well as profound bradycardia, bronchospasm, and rare allergic reactions such as anaphylaxis. Immediate medical attention is required if these symptoms occur.

Mestinon 10 is contraindicated in patients with known hypersensitivity to pyridostigmine or any component of the formulation, and in individuals with severe obstructive pulmonary disease where increased bronchial secretions could worsen breathing. Caution is also advised for patients with uncontrolled cardiac arrhythmias.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Pyridostigmine Bromide

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT